Long-chain N-acyl amino acid antibiotics isolated from heterologously expressed environmental DNA
Long-chain N-acyl amino acid antibiotics isolated from heterologously expressed environmental DNA
复制标题
DOI:
10.1021/ja002990u
复制
发表时间:
2000-12-27
影响因子:
15
通讯作者:
Clardy, J
中科院分区:
文献类型:
--
作者:
Brady, SF;Clardy, J
The tiny minority of soil microorganisms that can easily be cultured with standard techniques, roughly 0.1 to 1.0%, 1 produce a spectacular array of biologically active natural products. The uncultured majority likely produces natural products with chemical diversity and biological activity similar to that of cultured microorganisms. To access the natural products produced by uncultured microorganisms, 2 a cosmid library of DNA extracted directly from soil samples (environmental DNA, eDNA) was constructed and screened for the production of biologically active small molecules. 3 One of the active cosmid clones, CSL12, produces a series of long-chain N-acyl-L-tyrosine antibiotics. Long-chain N-acyl amino acids are a growing family of bacterial natural products for which no biosynthesis genes have yet been identified. Analysis of the eDNA cloned in CSL12 indicated that a single open reading frame (ORF) was responsible for the production of these antibiotics and thus led to the identification of what we believe to be the first long-chain N-acyl amino acid biosynthesis gene. In this communication we report the characterization of these new natural product antibiotics and the sequence for a long-chain N-acyl amino acid synthase. A sequential two antibiotic selection scheme was used to identify and then recover cosmid clones that produce antibacterial activities. The cosmid library of eDNA was originally selected on LB plates containing kanamycin and allowed to incubate at 30 C for 2-4 days. The mature colonies were then overlayed with top agar containing kanamycin resistant Bacillus subtilis. After an additional 24 h of incubation at 30 C, colonies that produced zones of growth inhibition in the B. subtilis lawn, indicating the production of antibacterial activity, were recovered by streaking bacteria picked from the active colonies onto LB plates containing ampicillin (50 μg/mL). The second selection, on ampicillin, removes the B. subtilis assay strain and allows for the recovery of antibacterial hits directly from the assay plates. Of the approximately 700 000 clones screened, 65 antibacterial active colonies were found. Since we were most interested in small molecule antibiotics, ethyl acetate extracts from small-scale cultures of the active clones were assayed for antibacterial activity. One of the clones that produced a very active organic extract, CSL12, was chosen for further characterization. When the purified cosmid from CSL12 was retransformed into E. coli, it continued to confer antibacterial activity indicating that the cloned eDNA was responsible for the observed activity.The active constituents in the ethyl acetate extract from cultures of CSL12 were isolated using a bioassay-guided fractionation against B. subtilis. Crude ethyl acetate extracts were obtained from neutralized cultures grown in LB (30 μg/mL of kanamycin) at 30 C for 60 h. The ethyl acetate extract was partitioned by normal phase flash chromatography (CHCl3: MeOH step gradient with 0.1% HOAc) and the active material that eluted from the silica column was then further partitioned by reversed-phase LC-CN flash chromatography (CH3CN: H2O step gradient with 0.1% triethylamine). Thirteen related compounds trivially named CSL12-A through CSL12-M were isolated by reversed-phase HPLC from the antibacterial active material that eluted from the second flash column. 4 The active material from the ethyl acetate extract of a 3.5 kb BamH I subclone of CSL12, CSL12. 1, produced an identical reversed-phase HPLC trace, and this subclone was used for the remainder of our characterization studies.